Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yoshitaka Honma
Association Between UGT1A1 Gene Polymorphism and Safety and Efficacy of Irinotecan Monotherapy as the Third-Line Treatment for Advanced Gastric Cancer
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
Association Between Serum Ligands and the Skin Toxicity of Anti-Epidermal Growth Factor Receptor Antibody in Metastatic Colorectal Cancer
Cancer Science
Cancer Research
Medicine
Oncology
Related publications
Irinotecan Monotherapy as Third-Line or Later Treatment in Advanced Gastric Cancer
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
Efficacy of Irinotecan as Third-Line Chemotherapy for Unresectable or Recurrent Gastric Cancer
In Vivo
Biochemistry
Medicine
Genetics
Pharmacology
Molecular Biology
Safety and Continuity of Second- And Third-Line Therapy With Paclitaxel or Irinotecan for Advanced and Recurrent Gastric Cancer
Molecular and Clinical Oncology
Cancer Research
Oncology
No Association Between EGF Gene Polymorphism and Gastric Cancer
Cancer Epidemiology Biomarkers and Prevention
Medicine
Epidemiology
Oncology
Association Between the XPG Gene Rs2094258 Polymorphism and Risk of Gastric Cancer
Journal of Clinical Laboratory Analysis
Allergy
Immunology
Biochemistry
Public Health
Medical Laboratory Technology
Clinical Biochemistry
Hematology
Microbiology
Environmental
Occupational Health
Prognostic Factors of Second and Third Line Chemotherapy Using 5-Fu With Platinum, Irinotecan, and Taxane for Advanced Gastric Cancer
Cancer Research and Treatment
Cancer Research
Oncology
Comparative Analysis of the Efficacy and Safety of Modified FOLFOX-6 and DCF Regimens as First-Line Treatment in Advanced Gastric Cancer
Molecular and Clinical Oncology
Cancer Research
Oncology
Clinical Significance of UGT1A1 Gene Polymorphisms on Irinotecan-Based Regimens as the Treatment in Metastatic Colorectal Cancer
OncoTargets and Therapy
Oncology
Pharmacology
Outcomes of Third-Line Docetaxel-Based Chemotherapy in Advanced Gastric Cancer Who Failed Previous Oxaliplatin-Based and Irinotecan-Based Chemotherapies
Cancer Research and Treatment
Cancer Research
Oncology
